Embryonic pluripotent cells are sensitive to genotoxicity though they need more stringent genome integrity to avoid compromising multiple cell lineages and subsequent generations. However it remains unknown whether the cells are susceptible to adrenergic stress which can induce somatic cell genome lesion. We have revealed that adrenergic stress mediators cause DNA damage of the cells through the β2 adrenergic receptor/adenylate cyclase/cAMP/PKA signalling pathway involving an induction of intracellular reactive oxygen species (ROS) accumulation. The adrenergic stress agonists adrenaline, noradrenaline, and isoprenaline caused DNA damage and apoptosis of embryonic stem (ES) cells and embryonal carcinoma stem cells. The effects were mimicked by β2 receptor-coupled signalling molecules and abrogated by selective blockade of β2 receptors and inhibition of the receptor signalling pathway. RNA interference targeting β2 receptors of ES cells conferred the cells the ability to resist the DNA damage and apoptosis. In addition, adrenergic stimulation caused a consistent accumulation of ROS in the cells and the effect was abrogated by β2 receptor blockade; quenching of ROS reversed the induced DNA damage. This finding will improve the understanding of the stem cell regulatory physiology/pathophysiology in an adrenergic receptor subtype signalling mechanism.
reported to trigger DNA damage through activation of adrenergic receptors in somatic cells, implicating an important mechanism underlying the stress-related diseases 5, [9] [10] [11] [12] [13] . Embryonic stem (ES) cells are derived from blastocyst that is regulated by adrenergic neuronal and humoral transmission [14] [15] [16] . The embryonic pluripotent cells are critical for the developing embryo and are known to be susceptible to genotoxicity though they are expected to need more stringent genome integrity to avoid compromising multiple cell lineages and subsequent generations [17] [18] [19] [20] . So the potential genotoxicity to the cells is raising concerns and need to be scrutinized 21 . However, it remains unknown whether the adrenergic stress mediators cause DNA damage in embryonic pluripotent cells and, if so, by which receptor signalling mechanism.
Here we have revealed that the adrenergic stress mediators lead to DNA damage and apoptosis of embryonic pluripotent cells. These effects are selectively mediated via β 2 adrenergic receptor/adenylate cyclase/cAMP/PKA signalling pathway involving an induction of intracellular ROS accumulation.
Results
Adrenergic stimulation induces embryonic pluripotent stem cell DNA damage and apoptosis.
Adrenergic mediators adrenaline and noradrenaline induced DNA damage in ES cells and ECS cells in a concentration-dependent manner, from 0.01 μ M to 10 μ M, as shown in western blotting analysis of γ -H2AX accumulation (Fig. 1A) , one of the earliest and most sensitive markers of DNA damage for double-strand breaks 22, 23 . The effect on the induction of DNA damage of adrenergic stress mediators was recapitulated by isoprenaline, an adrenergic β receptor agonist. Isoprenaline markedly induced γ -H2AX accumulation in ES cells assayed by western blotting (Fig. 1A) , HCA (Fig. 1B) , laser confocal imaging ( Supplementary Fig. S1A ), and flow cytometry (Fig. 1C ). This effect was confirmed by comet assay for the analysis of DNA breaks and LC-MS-MS for the analysis of 8-hydroxy-2′ -deoxyguanosine (8-OHdG), a specific marker for oxidative DNA damage. Comet assay showed that isoprenaline and H 2 O 2 induced the appearance of DNA breaks as the comet tails after single-cell gel electrophoresis (Fig. 1D) . Moreover, the accumulation of 8-OH-dG in ES cells was markedly induced by isoprenaline stimulation assayed by LC-MS/MS ( Fig. 2A and Supplementary Fig. S2 ).
Time kinetic experiment by LC-MS/MS showed that the accumulation of 8-OH-dG occurred at 1 h after the adrenergic stimulation and the increased levels of 8-OH-dG were maintained during the test duration of 24 h ( Fig. 2A) . This effect was confirmed by flow cytometry assay which showed that the damage occurred at 1 h after the adrenergic stimulation and the damage magnitude sustained during the test duration (Fig. 2B ). Damage to DNA led to cell death. Flow cytometry assay on Annexin V/PI showed that ES cells (Fig. 2C ) and ECS cells ( Supplementary Fig. S3A ) underwent apoptosis after the adrenergic stimulation, being more obvious at 24 h (Fig. 2C) . Incubation of isoprenaline at 10 μ M for 24 h increased the portion of Annexin V positive cells from 1.9 ± 0.85% to 16.2 ± 2.30%. The cell death were also confirmed by HCA of cell clone counting, which showed a decrease of ES cell clone formation number under the adrenergic stimulation ( Supplementary Fig. S3B ).
Neither adrenaline nor isoprenaline induced γ -H2AX accumulation in MEFs along the dose range ( Supplementary Fig. S1B and C), indicating that embryonic pluripotent cells are more sensitive to the adrenergic stimulation-induced DNA damage.
During the time, adrenergic stimulation did not trigger the pluripotent stem cell differentiation as determined by monitoring the pluripotency markers Oct4 and Sox2 and the differentiation markers Nestin and Sox17 (Fig. 1B, Supplementary Fig. S3C , and data not shown).
Adrenergic stimulation-induced DNA damage is caused by β2 adrenergic receptor signalling-generated intracellular ROS accumulation. The transcripts of β 2 receptors and β 3 receptors were expressed in ES cells and ECS cells as determined by RT-PCR analysis (Fig. 3A) . Expression of the receptors was confirmed by immunocytofluorescence staining analysis in ES cells and ECS cells (Fig. 3B ). β 2 receptors or β 3 receptors colocalized with the pluripotent marker Oct4 in the same undifferentiated pluripotent cells and the β 2 receptors were expressed in higher intensity than the β 3 receptors in the pluripotent cells (Fig. 3B ). MEFs were also detected to express β 2 receptors (Fig. 3B) .
The β receptors in the embryonic pluripotent cells were functional because agonist stimulation of the receptors led to an accumulation of intracellular cAMP (Fig. 3C) , the secondary messenger generated after the receptor activation via coupled Gs protein-adenylate cyclase (AC) signalling pathway. After pre-incubation with IBMX, a nonselective phosphodiesterase inhibitor, the β receptor activation-induced cAMP accumulation was augmented as expected and AC activator forskolin also markedly increase cAMP accumulation as expected (Fig. 3C) .
The adrenergic activation-induced cAMP accumulation in embryonic pluripotent cells selectively depended on β 2 receptors because the effect in ES cells was fully abrogated by nonselective β receptor antagonist propranolol or β 2 receptor selective antagonist ICI118551 whereas SR59230A, a β 3 receptor selective antagonist showed much less impact on the effect (Fig. 3D) .
Accordingly, the adrenergic stimulation-induced DNA damage in embryonic pluripotent cells also depended on β 2 receptors. The DNA damage was blocked by propranolol, ICI118551, but not by SR59230A (Fig. 4A,B) . Furthermore, when the β 2 receptors of the ES cells were knocked down, the cells showed fully resistant to isoprenaline-induced DNA damage (Fig. 4C) . This also indicates that the DNA damage-induction effect is directly ascribed to the β 2 receptors expressed in ES cells rather than indirectly to those of MEFs.
Damage to DNA leads to ES cell apoptosis. Adrenergic stimulation markedly increased the portion of Annexin V-positive ES cells. The effect was abrogated by β receptor blockade or β 2 receptor-specific blockade whereas β 3 receptor-specific blockade failed to inhibit the effect (Fig. 4D ). The β 2 receptor-mediated mechanism was confirmed by the knockdown of β 2 receptors in ES cells. In these cells, the adrenergic stimulation-induced apoptosis was completely abrogated (Fig. 4E) .
Stimulation of β 2 receptor initiates the activation of AC, leading to an increase of cAMP and subsequent activation of PKA. Accordingly, AC activator forskolin increased an accumulation of γ -H2AX in ES cells, mimicking the effect of β 2 receptor activation whereas PKA inhibitor H89 markedly abrogated forskolin-and adrenergic stimulation-induced DNA damage assayed by Western blot (Fig. 5A ), flow cytometry ( Fig. 5B) and HCA (Fig. 5C) .
In addition to AC/cAMP/PKA signalling pathway, β -arrestin/MDM2/p53 pathway has been reported to partially contribute to β receptor stimulation-induced DNA damage in somatic cells 11 . In ES cells, isoprenaline in 10 μ M did not induce MDM2 activation or downregulate p53 expression ( Supplementary  Fig. S4A-C) . Moreover, the knockdown of Arrb1 (β -arrestin-1) or Arrb2 (β -arrestin-2) in ES cells failed to abrogate the β receptor stimulation-induced DNA damage ( Supplementary Fig. S4D,E) . These indicate 
Generation of intracellular ROS is one of the prominent causes leading to DNA damage. Stimulation of β receptors increased intracellular ROS content in ES cells as showed by flow cytometry (Fig. 5D) and HCA (Fig. 5E ) using redox sensitive fluorescent probe DCFDA. The increased levels of ROS were maintained during the time course of test, from 5 min after exposure to isoprenaline until 15 min (Fig. 5D ). This indicates an adrenergic stimulation-induced source of ROS accumulation. Accordingly the amount of oxidative DNA damage marker 8-OH-dG was considerably increased (Supplementary Fig. S5 ). The effect was significantly abrogated by β 2 receptor blockade (Fig. 5D,E and Supplementary Fig. S5 ). When the accumulated ROS was quenched by NAC, the isoprenaline-induced γ -H2AX accumulation was blocked (Fig. 5F ), suggesting the role of ROS on the the adrenergic stimulation-caused DNA damage.
Discussion
The key finding in this study is that adrenergic stress mediators causes DNA damage of embryonic pluripotent cells through the induction of intracellular ROS accumulation and that the effect is mediated by β 2 adrenergic receptor and its cognate AC/cAMP/PKA signalling pathway.
Genotoxic effects of radiation and xenobiotics on embryonic pluripotent cells have been extensively studied whereas those from stress mediators are much less explored. Discovering the genotoxic properties of adrenergic stress mediators to embryonic pluripotent cells and delineating the underlying receptor subtype mechanism will improve the understanding of stem cell biology and physiology/pathophysiology and help to design strategies to modulate/protect the stem cells by targeting adrenergic signalling pathways in a selective way.
Adrenergic responses prepare the body for coping with the perceived threats and are crucial for the adaptation and harmony of the organism 3, 24 . However, excessive adrenergic stress responses involving the stress mediator-induced cell DNA damage in somatic cells impair body homeostasis and contribute to numerous diseases 5, [9] [10] [11] [12] [25] [26] [27] . In hematopoietic progenitor cells, adrenergic agonists have been reported to induce DNA damage and inhibition of cell proliferation 28 . In embryonic pluripotent cells, we for the first time found that the adrenergic stress agonists adrenaline, noradrenaline, and isoprenaline caused DNA damage and apoptosis. The effects were mimicked by β 2 receptor-coupled signalling molecules and abrogated by selective blockade of β 2 receptors and inhibition of the receptor signalling pathway. RNA interference targeting β 2 receptors of ES cells conferred the cells the ability to resist the adrenergic stress-induced DNA damage and apoptosis. In addition, adrenergic stimulation caused a consistent accumulation of ROS in ES cells, and the effect was abrogated by β 2 receptor blockade. Quenching of ROS reversed the adrenergic stress-induced DNA damage, indicating the involvement of ROS accumulation of β 2 receptor signalling for the induction of the damage.
ROS can be endogenously produced during oxidative metabolism. Though important for physiological processes such as signal transduction, excessive generation of ROS causes damage to DNA in somatic and stem cells 29, 30 . Keeping a balanced ROS level is crucial for the homeostasis and well-being of the organism. In hematopoietic stem cells, ROS accumulation and ROS-induced DNA damage limits the lifespan of the cells and contributes to the exhaustion of the stem cell population and the dysfunction of the cells 30, 31 . Compared with somatic cells, stem cells bear a lower baseline level of oxidative burden to protect genome integration by low mitochondrial biogenesis, reduced oxygen consumption and ATP generation through anaerobic glycolysis rather than oxidative phosphorylation and are sensitive to increased ROS 32, 33 . Adrenergic stress induced an marked accumulation of ROS in embryonic pluripotent cells, thus causing a damage to DNA.
Activation of β 2 receptors increased ROS in embryonic pluripotent cells via AC/cAMP-PKA signalling pathway. In cardiomyocytes, β 2 receptor stimulation induces ROS accumulation via the activation of NADPH oxidase, leading to cardiomyopathy 34 . Activation of cAMP/PKA signalling similarly results in an increase in mitochondrial ROS production 35, 36 . The increased ROS production induced by β receptor stimulation is a direct consequence of cAMP-PKA-dependent signalling and relies on the modulation of SOD expression or mitochondria function by the receptor signalling 35, [37] [38] [39] . Damage to DNA triggers a cascade of signalling events defined as the DNA damage response (DDR) including DNA repair 1, 40 . After DNA damage induced by adrenergic stimulation, embryonic pluripotent cells underwent apoptosis, suggesting that the damage was too excessive to be properly corrected and that the cells were then programmed to undergo apoptosis to eliminate potentially dangerous cells carrying defective DNA. This will limit the transmission of the damaged genome to the progeny cells 41 . While this mechanism prevent mutations from propagating to the developing embryos, it depletes stem cell pool and potentially impairs tissue maintenance and induces aging 42 . The embryonic pluripotent cells bearing damaged DNA underwent apoptosis and maintained their pluripotency markers, consistent with the report that ES cells are able to keep their self-renewal capacity under the H 2 O 2 -induced cell cycle arrest and apoptosis 43 . This implies that stem cells are able to take advantage of cell cycle checkpoints trying to limit genome lesion and maintain self-renewal 44 . Cell cycle arrest, allowing time and opportunity for the repair of DNA, is one of the core events in DDR 1 . We have found that under adrenergic stress mediator stimulation, embryonic pluripotent cells undergo cell cycle arrest and proliferation inhibition 45 . It would be worth further exploring whether the cell cycle arrest is attributed to the induced DNA damage response. DNA damage, which is apt to leads to mutation and genome instability, must be keep low in ES cells and early embryos in this critical stage of development 46, 47 . Defects in their genome will have devastating consequences and even affect subsequent generations when the cells recreate the entire organism and the germ cells. Accumulated DNA damage is also a principal mechanism underlying stem decline in many diseases 48 . Thus adrenergic stress, which causes DNA damage via induction of the accumulation of ROS by activation of β 2 receptor signalling, will compromise embryonic pluripotent cells and the well-being of the whole organism. It is worth confirming whether β receptors represent a novel target for the protection of embryonic pluripotent cells from DNA damage and subsequent genome instability insulted by adrenergic stress. It is expecting in terms of a translational view considering the great success of β receptor blockers in drug development and disease therapy 49, 50 .
Material and Methods
Materials. Dulbecco's Modified Eagle's Medium (DMEM), KnockOut-Dulbecco's modified eagle medium (KO-DMEM), fetal bovine serum (FBS), KnockOut Serum Replacement (KSR), β -mercaptoethanol, L-glutamine, non-essential amino acids (NEAA), and GlutaMAX were purchased from GIBCO/ Life Science. Leukemia inhibitory factor (LIF) was purchased from Chemicon. Isoprenaline, ICI118551, and SR59230A were purchased from Tocris Bioscience. 5-(and-6)-carboxy-2′ ,7′ -dichlorofluorescin diacetate (carboxy-DCFDA), 8-Hydroxy-2′ -deoxyguanosine (8-OH-dG) and N-acetyl-L-cysteine (NAC) were purchased from Sigma-Aldrich. Forskolin and H89 were purchased from Beyotime. HPLC-grade methanol, water, and formic acid were purchased from Merck. Rabbit polyclonal anti-β 3 receptor antibody, mouse monoclonal anti-Oct4 antibody, rabbit polyclonal anti-MDM2 antibody, and mouse monoclonal anti-β -Arrestin-1/2 antibody were purchased from Santa Cruz. Rabbit polyclonal anti-β 2 receptor antibody was purchased from Abcam. Rabbit monoclonal anti-phospho-histone H2AX antibody, mouse monoclonal anti-p53 antibody, and rabbit polyclonal anti-phospho-MDM2 (Ser166) antibody were purchased from Cell Signalling Technology.
Cell culture. The mouse R1 ES cell line was obtained from the Institute of Biochemistry and Cell Biology of the Chinese Academy of Sciences (Shanghai, China). The mouse P19 ECS cell line was obtained from the Cell Bank of Type Culture Collection of the Chinese Academy of Sciences (Shanghai, China). The culture and monitoring of pluripotency of the embryonic pluripotent cells were performed as described in our previous report 51, 52 . ES cells were grown with irradiated mouse embryonic fibroblasts (MEFs) as feeder layer in KO-DMEM supplemented with 1/10000 (v/v) LIF, 1/500 (v/v) β -mercaptoethanol, 1/100 (v/v) L-glutamine, 1/100 (v/v) non-essential amino acids, and 15% FBS. ECS cells were grown in DMEM supplemented with 10% FBS and 1% GlutaMAX. The cells were maintained at 37 °C in a humidified atmosphere containing 5% CO 2 and 95% air.
Western blotting. Cell lysates were resolved by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), transferred onto PVDF membranes (Millipore), blocked in 5% nonfat milk, and incubated with appropriate primary antibodies overnight at 4 °C. After incubated with the corresponding secondary antibodies the immunoblots were visualized and scanned by using the Odyssey FC Imaging System (LI-COR Biosciences).
High-content analysis. Image-based high-content analysis 53, 54 was performed by using the HCA System (ArrayScan XTI, Thermo Scientific). Cells were incubated with appropriate first antibodies and then the corresponding fluorescence-conjugated second antibodies for the quantitative determination of the protein expression levels. Cell nuclei were counterstained with DAPI and the cell pluripotency was monitored by Oct4 immunofluorescence staining.
Comet assay (Single cell gel electrophoresis assay). The alkaline comet assay was carried out as previously described with minor modifications 55 . The cells were mixed with 0.5% low-melting agarose and applied to glass slides pre-coated with 1% normal-melting agarose. Slides mounted with cells were immersed in cold lysing solution (2.5 M NaCl, 100 mM EDTA, 10 mM Tris base, 1% Triton X-100, 10% DMSO, 200 mM NaOH, pH = 10) for 2.5 h at 4 °C. Then electrophoresis was conducted at 300 mA for 20 min in the dark. After neutralized in 0.4 M Tris-HCl for 5 min, the slides were dipped in ethanol and air-dried in the dark. Cells were stained with SYBR Green I and observed by using a fluorescence microscope (Leica TCS-NT). A total of 100 cells per sample was analyzed for the percentage of DNA in the comet tail by using the Komet software program v5.5.
Flow cytometry.
Cell samples were analyzed with a flow cytometer (Accuri C6, BD Biosciences).
Fixed and permeated cells were incubated with anti-phospho-histone H2AX antibody and the corresponding fluorescence-conjugated second antibody for the detection of DNA damage. The fluorescent oxidation indicator carboxy-DCFDA was used to quantify the intracellular reactive oxygen species (ROS) levels. Annexin V/PI apoptosis detection Kit (BD Biosciences) was used to determine cell apoptosis. A total of 10,000 cells was analyzed per sample.
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Measurement of 8-OH-dG content by Liquid chromatography/mass spectrometry (LC-MS/MS).
Calibration standards were prepared at concentrations of 2, 5, 10, 20, 50 and 100 ng/mL by diluting a fixed amount of stock solution of 8-OH-dG in methanol/water (4:1, v/v) in tubes. All calibration standards were stored at − 70 °C until the LC-MS/MS analysis.
LC was performed on a Shimadzu prominence UFLC-XR system (Shimadzu), and separation was carried out at 35 °C by using an Agilent Eclipse XDB-C18 column (4.6 × 150 mm, 5 μ m). Methanol (solvent A) and 0.1% formic acid in water (solvent B) were used as mobile phases, and the flow rate was set at 0.30 mL/min. The gradient started with 60% of mobile phase A, increasing to 100% at 6 min. The mobile phase was held isocratic for 1 min before returning to 60% mobile phase A, then for 2 min to equilibrate the column and reestablish the C18 condition (total run time was 9 min). The injection volume was 5 μ L.
The LC system was coupled to a triple quadrupole mass spectrometer (API-4000, AB SCIEX). Conditions for Declustering Potential (DP), Collision Energy (CE) and Exit Cell Potential (CXP) for each analyte were obtained by using the Quantitative Optimization function in the analyst software. An electrospray ionization (ESI) in positive ionization mode was used. Unless otherwise specified, the ESI source parameters were set as: curtain gas, 35 psi; gas flows (GS1, GS2), 50 psi; gas temperature (TEM), 550 °C. The mode of multiple reaction monitoring (MRM) was used to identify and quantify 8-OH-dG (transition: m/z 284.2 [M + H] + → 168.1, DP 50 V, collision energy 15 eV).
In sample preparation procedure, 100 μ L of sample was mixed with 200 μ L of chilled methanol (containing 0.3% formic acid). The mixture was vortexed for 30 seconds and centrifuged at 13,000 g, for 10 min. The supernatant (5 μ L) was subjected to the LC-MS/MS analysis.
Other LC-MS/MS procedures were performed as described in our previous reports 52, 56, 57 .
RNA isolation and reverse transcript PCR. Total RNA from cells was isolated with RNA Extraction Kit (Omega) according to the manufacturer's instructions. Reverse transcription (RT) was carried out using a RevertAid First Strand cDNA Synthesis Kit (Invitrogen). The resultant cDNA was amplified according to the following temperature profile: 94 °C for 30 s, 55 °C for 45 s, and 72 °C for 1 min. At the end of 31 cycles, the reaction was continued for an additional 10 min at 72 °C. The amplified cDNA was subjected to 2% agarose gel electrophoresis. The primer sequences used for reverse transcript PCR are shown in Supplementary Table S1 :
Immunofluorescence staining. Cells were seeded into multiple glass-bottom tissue culture plates (10 mm; Shengyou Biotechnology) and cultured for 24 h. After fixed the cells were blocked with 1% bovine serum albumin (BSA) for 60 min at 37 °C and incubated overnight at 4 °C with primary antibodies (1:400 for anti-phospho-H2AX, 1:300 for anti-β 2 receptor, 1:300 for anti-β 3 receptor, and 1:200 for anti-Oct4). Next, the cells were incubated for 1 h at 37 °C with the corresponding secondary antibodies and then subjected to laser confocal microscopy (Leica SP8) analysis.
RNA interference. β 2-AR shRNA and nontarget control shRNA lentiviral particles were purchased from Santa Cruz Biotechnology. The RNA interference procedure was performed according to the manufacturer's instruction. Levels of the receptor protein expression were detected by western blotting.
Determination of cAMP level. Cells were detached and resuspended in assay buffer. Intracellular cAMP determination assay was carried out by using a cAMP dynamic kit based on homogenous time-resolved fluorescence (HTRF) technology according to the manufacturer's instructions (CisBio International) and the florescent signals were read in a plate reader (EnVision, Perkin-Elmer).
Statistical analysis. Statistical significance was tested by using a Student's test or an one-way ANOVA with Bonferroni post-test properly. Differences were considered statistically significant when P < 0.05.
